Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of 0.13 is 128% above its 4-year average of -0.46, near the high end of its 4-year range (-1.05–0.13).
316.67% above its 12-month average of -0.06.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): 0.06.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 14 comparable quarters.
FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T22:22:30.362Z. Historical observations retain their original dates. Historical series through 2026-10-05.
EARNINGS PER SHARE (EPS)
0.13
EARNINGS PER SHARE (EPS) AVG TTM
-0.06
EARNINGS PER SHARE (EPS) AVG 3Y
-0.31
EARNINGS PER SHARE (EPS) AVG 5Y
-0.46
EARNINGS PER SHARE (EPS) AVG 10Y
N/A
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
+316.67%
CURRENT VS 3Y AVG
+141.94%
CURRENT VS 5Y AVG
+128.38%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
LifeStance Health Group, Inc.
Market Cap
$4.70B
Earnings Per Share (EPS)
0.13
TTM Avg
-0.06
3Y Avg
-0.31
5Y Avg
-0.46
Market Cap
$4.73B
Earnings Per Share (EPS)
-3.43
TTM Avg
-1.80
3Y Avg
-1.89
5Y Avg
-2.15
Market Cap
$4.64B
Earnings Per Share (EPS)
1.33
TTM Avg
1.25
3Y Avg
1.21
5Y Avg
0.93
Market Cap
$4.78B
Earnings Per Share (EPS)
-0.13
TTM Avg
-3.38
3Y Avg
-5.70
5Y Avg
-8.99
Market Cap
$4.60B
Earnings Per Share (EPS)
0.62
TTM Avg
-0.43
3Y Avg
-0.91
5Y Avg
-0.91
Market Cap
$4.83B
Earnings Per Share (EPS)
-14.56
TTM Avg
-1.16
3Y Avg
-2.58
5Y Avg
-2.86
Market Cap
$4.84B
Earnings Per Share (EPS)
-2.47
TTM Avg
-3.65
3Y Avg
-5.00
5Y Avg
-7.51
Market Cap
$4.48B
Earnings Per Share (EPS)
2.79
TTM Avg
0.85
3Y Avg
0.10
5Y Avg
0.11
Market Cap
$4.96B
Earnings Per Share (EPS)
-0.95
TTM Avg
-0.56
3Y Avg
-0.99
5Y Avg
-0.97
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| LifeStance Health Group, Inc. (LFST) | $4.70B | 0.13 | -0.06 | -0.31 | -0.46 |
| Definium Therapeutics, Inc. (DFTX)vs › | $4.73B | -3.43 | -1.80 | -1.89 | -2.15 |
| Option Care Health, Inc. (OPCH)vs › | $4.64B | 1.33 | 1.25 | 1.21 | 0.93 |
| Dianthus Therapeutics, Inc. (DNTH)vs › | $4.78B | -0.13 | -3.38 | -5.70 | -8.99 |
| BillionToOne, Inc. (BLLN)vs › | $4.60B | 0.62 | -0.43 | -0.91 | -0.91 |
| Mirum Pharmaceuticals, Inc. (MIRM)vs › | $4.83B | -14.56 | -1.16 | -2.58 | -2.86 |
| Oruka Therapeutics, Inc. (ORKA)vs › | $4.84B | -2.47 | -3.65 | -5.00 | -7.51 |
| Indivior Pharmaceuticals Inc (INDV)vs › | $4.48B | 2.79 | 0.85 | 0.10 | 0.11 |
| Erasca, Inc. (ERAS)vs › | $4.96B | -0.95 | -0.56 | -0.99 | -0.97 |
| Heartflow, Inc. Common Stock (HTFL)vs › | $4.37B | -1.42 | -1.45 | -1.45 | -1.45 |
Trailing EPS (TTM)
$0.13
Forward EPS (Est.)
$0.16
P/E Ratio
93.5
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | 0.03 |
| 2024-12-31 | -0.15 |
| 2023-12-31 | -0.51 |
| 2022-12-31 | -0.61 |
| 2021-12-31 | -1.05 |
| 2019-12-31 | -0.16 |
